In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" cancer treatments for more patients.
from News Medical Medical Research News Feed https://ift.tt/3sLLLkl
0 Comments